Physician profile
Duc T Bui
NPI 1386663896
$6,248.36
in general payments reported to CMS, 2019-2025
25 companies · $1,758 in 2025
The $1,758 reported for 2025 was more than what 81% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $146 · 2021: $115 · 2022: $253 · 2023: $1,936 · 2024: $1,201 · 2025: $1,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,395 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,394.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $1,500.00 | 2023 | |
| Abbvie INC. | $713.64 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Avita Medical Americas, LLC | $678.72 | 2024-2025 | Recell, Cohealyx, Permeaderm |
| Integra Lifesciences Corporation | $471.37 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $342.62 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Polynovo North America LLC | $332.25 | 2025 | Novosorb Btm |
| Davol INC. | $256.05 | 2024-2025 | Phasix Mesh, Arista Ah Flexitip |
| Sientra, INC. | $254.54 | 2019 | |
| Organogenesis INC. | $233.74 | 2024-2025 | Puraply Wound Matrix |
| Convatec INC. | $228.04 | 2019 | |
| Solventum Corporation | $168.75 | 2024 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Smith+Nephew, INC. | $168.55 | 2019-2022 | |
| Kci USA, INC. | $137.15 | 2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Allergan, INC. | $123.79 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $99.31 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $93.52 | 2023 | |
| Axogen | $85.11 | 2025 | |
| Stryker Corporation | $83.76 | 2020-2024 | Stryker |
| Musculoskeletal Transplant Foundation INC. | $79.59 | 2023-2025 | |
| Innovation Technologies INC | $74.89 | 2025 | Irrisept |
| Kerecis Limited | $35.59 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Access Pro Medical, LLC | $34.55 | 2025 | Matriderm |
| Derma Sciences, INC. | $23.95 | 2019 | |
| Coopersurgical, INC. | $15.93 | 2025 | Insorb |
| Endo Pharmaceuticals INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duc Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.